Q4 2018

Filed Mar 22, 2019 · 10-K · 81 days after period end · 0001564590-19-009031

Q4 2018 · 10-K

Revenue—

Net Income

-$38.79M

no prior Q4 2017 on file

EPS Diluted

-$4.92

no prior Q4 2017 on file

Operating Income-$39,807,000—

Operating Cash Flowderived-$25,023,000—

Same quarter

no prior Q4 2017 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ended Dec 31, 2018 · filed Mar 22, 2019 · 81 d after period end

Gossamer Bio, Inc. · CIK 1728117 · Engraved from SEC EDGAR